missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ MOB1A/B Recombinant Rabbit Monoclonal Antibody (5B8X6)
Description
Immunogen Sequence: MSFLFSSRSS KTFKPKKNIP EGSHQYELLK HAEATLGSGN LRQAVMLPEG EDLNEWIAVN TVDFFNQINM LYGTITEFCT EASCPVMSAG PRYEYHWADG.
The protein encoded by this gene is a component of the Hippo signaling pathway, which controls organ size and tumor growth by enhancing apoptosis. Loss of the encoded protein results in cell proliferation and cancer formation. The encoded protein is also involved in the control of microtubule stability during cytokinesis. Several transcript variants encoding different isoforms have been found for this gene.
Spécification
Spécification
| Antigène | MOB1A/B |
| Applications | ELISA, Western Blot, Immunocytochemistry |
| Classification | Recombinant Monoclonal |
| Clone | 5B8X6 |
| Concentration | 1.98 mg/mL |
| Conjugué | Unconjugated |
| Formule | PBS with 0.05% BSA, 50% glycerol and 0.05% ProClin 300; pH 7.3 |
| Expression | Mob1b |
| Numéro d’ordre du gène | Q3T1J9, Q7L9L4, Q8BPB0, Q921Y0, Q9H8S9 |
| Alias de gène | 1110003E08Rik; 4022402H07Rik; AU015450; B230364F10; C2orf6; MATS1; MATS2; MOB kinase activator 1A; MOB kinase activator 1B; MOB1; Mob1 alpha; mob1 homolog 1A; Mob1 homolog 1B; MOB1 Mps One Binder homolog A; MOB1 Mps One Binder homolog B; MOB1, Mps One Binder kinase activator-like 1A; MOB1, Mps One Binder kinase activator-like 1B; mob1A; Mob1b; MOB4A; MOB4B; Mobk1b; MOBKL1A; MOBKL1B; MOBKL1B/MOB4A; mps one binder kinase activator-like 1A; Mps one binder kinase activator-like 1B; Protein Mob4B |
| Afficher plus |
Nom du produit
En cliquant sur Soumettre, vous reconnaissez que vous pouvez être contacté par Fisher Scientific au sujet des informations que vous avez fournies dans ce formulaire. Nous ne partagerons pas vos informations à d'autres fins. Toutes les informations de contact fournies seront également conservées conformément à notre politique de confidentialité. Politique de confidentialité.
Vous avez repéré une opportunité d'amélioration ?